ANGIE CATLIN: Open Payments
NPI 1679051486 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 96 payments from 9 companies in 2025. Trend: 2023 $312 · 2024 $581 · 2025 $1,990
Food & beverage: $1,422Consulting: $555Education: $13
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 39 | $1,166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $287 |
| Otsuka America Pharmaceutical, Inc. | 12 | $181 |
| Vanda Pharmaceuticals Inc. | 12 | $140 |
| Lundbeck LLC | 3 | $77 |
| Alkermes, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, CAPLYTA, REXULTI, FANAPT, ABILIFY MAINTENA, VRAYLAR, VIVITROL, ARISTADA.
Industry payments across NY — which companies pay providers there.
